These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States. Rinckel LA; Buno BR; Gierman TM; Lee DC Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024 [TBL] [Abstract][Full Text] [Related]
3. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19. Baylis SA; Buchheit KH Vox Sang; 2009 Jul; 97(1):13-20. PubMed ID: 19416495 [TBL] [Abstract][Full Text] [Related]
4. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors. Sakata H; Matsubayashi K; Ihara H; Sato S; Kato T; Wakisaka A; Tadokoro K; Yu MY; Baylis SA; Ikeda H; Takamoto S Transfusion; 2013 Oct; 53(10 Pt 2):2556-66. PubMed ID: 23145866 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443 [TBL] [Abstract][Full Text] [Related]
6. Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay. Koppelman MH; van Swieten P; Cuijpers HT Transfusion; 2011 Jun; 51(6):1346-54. PubMed ID: 21175647 [TBL] [Abstract][Full Text] [Related]
7. Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays. Baylis SA; Ma L; Padley DJ; Heath AB; Yu MW; Vox Sang; 2012 Apr; 102(3):204-11. PubMed ID: 21988191 [TBL] [Abstract][Full Text] [Related]
8. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA. Koppelman MH; Cuijpers HT; Wessberg S; Valkeajärvi A; Pichl L; Schottstedt V; Saldanha J Transfusion; 2012 Jul; 52(7):1498-508. PubMed ID: 22587637 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP; Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland. Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352 [TBL] [Abstract][Full Text] [Related]
11. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. Baylis SA; Shah N; Minor PD J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors. Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724 [TBL] [Abstract][Full Text] [Related]
14. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010]. Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291 [TBL] [Abstract][Full Text] [Related]
15. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors. Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India. Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040 [TBL] [Abstract][Full Text] [Related]
18. Effects of probe binding mutations in an assay designed to detect parvovirus B19: implications for the quantitation of different virus genotypes. Baylis SA; Fryer JF; Grabarczyk P J Virol Methods; 2007 Jan; 139(1):97-9. PubMed ID: 17045660 [TBL] [Abstract][Full Text] [Related]
19. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Modrof J; Berting A; Tille B; Klotz A; Forstner C; Rieger S; Aberham C; Gessner M; Kreil TR Transfusion; 2008 Jan; 48(1):178-86. PubMed ID: 17900278 [TBL] [Abstract][Full Text] [Related]
20. Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA. Molenaar-de Backer MW; de Waal M; Sjerps MC; Koppelman MH Transfusion; 2016 Feb; 56(2):440-8. PubMed ID: 26354230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]